Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-25-004849

Chief Development Officer acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Turner William D. Chief Development Officer 2025-02-18 Grant or award +22,500 22,500 D
Derivatives
Turner William D. Chief Development Officer 2025-02-18 Grant or award · Stock Option (right to buy) +45,000 45,000 D
Loading xslF345X05/form4-02202025_090246.xml…